Regulations.gov document
Guidance for Industry Developing Medical Imaging Drug and Biological Products Part 3…
Other · FDA-1998-D-0035 · posted Jun 22, 2004
Key facts
| Document ID | FDA-1998-D-0035-0013 |
|---|---|
| Title | Guidance for Industry Developing Medical Imaging Drug and Biological Products Part 3: Design, Analysis and Interpretation of Clinical Studies |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-1998-D-0035 |
| Posted | Jun 22, 2004 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: